Histologically Remarkable Eosinophilic Esophagitis Responsive to Dupilumab in a Gastrostomy Tube-Dependent Pediatric Patient on Amino Acid Formula.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal titleJPGN reports
Publication Begin pagee250
MetadataShow full item record
AbstractEosinophilic esophagitis (EoE), an eosinophil predominant, TH2-mediated condition increasing in prevalence in pediatric and adult populations, is typically treated with dietary manipulations to avoid triggering antigens. However, identifying specific dietary causes remains a persistent challenge, and restrictive diets are burdensome. Total dietary modification using amino acid-based formula does not always produce symptomatic or histologic resolution, suggesting that exposure to ingested aeroallergens drives their disease. EoE patients demonstrate symptomatic exacerbation from July to September correlating with higher grass and ragweed pollen counts. We present a 7-year-old tracheostomy- and gastrostomy-dependent girl who was found on surveillance endoscopy to have profound eosinophilic infiltration throughout the esophagus with inflammatory changes including basal cell hyperplasia on histology. She responded partially to topical corticosteroid therapy with fluticasone and had complete resolution of esophageal eosinophilic infiltrate with subcutaneous dupilumab.
CitationCastro K, Arostegui D, Schwarz S, Gandhi S, Peshimam J, Rabinowitz S, Pittman M, Wallach T. Histologically Remarkable Eosinophilic Esophagitis Responsive to Dupilumab in a Gastrostomy Tube-Dependent Pediatric Patient on Amino Acid Formula. JPGN Rep. 2022 Sep 1;3(4):e250. doi: 10.1097/PG9.0000000000000250. PMID: 37168474; PMCID: PMC10158404.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
- Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
- Authors: Munoz-Persy M, Lucendo AJ
- Issue date: 2018 May
- Real World Experience With Dupilumab in Eosinophilic Esophagitis in Children and Young Adults at a Tertiary Care Pediatric Medical Center.
- Authors: Syverson EP, Rubinstein E
- Issue date: 2022 May
- Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens.
- Authors: Reed CC, Iglesia EGA, Commins SP, Dellon ES
- Issue date: 2019 Mar
- Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.
- Authors: Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A
- Issue date: 2020 Jan
- Eosinophilic Esophagitis: A Review.
- Authors: Muir A, Falk GW
- Issue date: 2021 Oct 5